Trial Overview
NCT ID: NCT07408193 Phase: EARLY_PHASE1 Enrollment Target: 24 Status: Recruiting
This is a randomized, double-blinded, placebo-controlled, cross-over trial examining the effect of a series of two weekly intravenous infusions of lidocaine 4 mg/kg and ketamine 0.2 mg/kg in patients with moderate to severe opioid-refractory chronic cancer-related pain. The aim of this study is to investigate whether the lidocaine - ketamine (LK) regimen provides better analgesia that an active placebo of midazolam 0.02 mg/kg, in this population.
Why This Matters
[Draft — editorial context needed]
Source
Event Website
ClinicalTrials.gov
